Abbott

The official LinkedIn page for the University of Nebraska, the only public research university in the state of Nebraska.

The largest university in the state, the University of Nebraska at Lincoln offers academic programs and research that have long placed it at the forefront of education. For example, University of Nebraska is one of the first universities to establish a major in Digital Humanities, offered through the English Department. In the same department, graduate students may undertake UNL’s prestigious MFA program in Creative Writing, which has leading writers among its faculty and is also responsible for founding one of the country’s most respected university literary publications. On the fine arts end of things, UNL boasts top museums and galleries with collections by some of the world’s most revered artists. UNL also has a natural history museum, which features fossils and other types of ancient excavations. Additional areas of study include: *Agricultural Sciences *Architecture *Education *Engineering *Law *Liberal Arts and Humanities *Performing Arts *Mass Communications UNL has long been distinguished for its research activity as well, conducting valuable research in a variety of scientific and other fields.

Bigfoot Biomedical, Inc. is a medical device company focused on transforming diabetes care for individuals with Type 1 Diabetes. Established in 2014 and based in Milpitas, California, the company specializes in developing an integrated diabetes management system that features cloud connectivity and human-centered automation. This system optimizes insulin dosing and delivery through a combination of automated infusion pumps and connected insulin pen options. Bigfoot Biomedical's innovative approach employs machine learning and user-friendly technologies to alleviate the cognitive, emotional, and financial burdens associated with insulin-requiring diabetes. By offering a comprehensive digital drug delivery platform through a unique monthly subscription service model, the company aims to enhance the quality of life for patients managing their diabetes.

Cardiovascular Systems, Inc., established in 1989, specializes in developing and marketing innovative medical technologies for treating peripheral and coronary artery diseases. The company's primary product line is its orbital atherectomy systems, which employ a diamond-coated crown to remove plaque from arteries above and below the knee. These catheter-based platforms are designed to tackle challenging disease states, including calcium buildup, which is particularly prevalent in peripheral artery disease (PAD) and coronary artery disease (CAD). Cardiovascular Systems generates most of its revenue through sales of these peripheral orbital atherectomy systems in the United States.

Easterseals is a nonprofit organization founded in 1944, dedicated to ensuring that individuals with disabilities have equal opportunities to live, learn, work, and play. The organization has developed a range of programs to meet the diverse needs of its clients, including summer camps for children with disabilities and youth leadership initiatives that empower young individuals to recognize their abilities and contribute to their communities. Easterseals is a pioneer in utilizing assistive technology to enhance independence for people with disabilities, offering access to a variety of adaptive devices and support through its Assistive Technology Regional Centers. Additionally, Easterseals provides comprehensive rehabilitation services, including physical, occupational, and speech therapy, and offers job training and employment services to help individuals with disabilities gain meaningful employment. With a commitment to advocacy, Easterseals also engages with legislators to address the needs of people with disabilities. In recent years, the organization has benefited thousands of individuals and families, illustrating its lasting impact in the communities it serves.

Howard University, located in Washington, D.C., is an esteemed institution established in 1867 that focuses on providing educational opportunities, particularly for African-American students. The university offers a wide range of academic programs at the undergraduate, graduate, and doctoral levels, including fields such as law, medicine, and pharmaceutical studies. With a commitment to fostering high academic achievement and potential, Howard University aims to enhance the educational landscape while reflecting the political and cultural dynamics of its environment.

Walk Vascular is a commercial-stage medical device company focused on addressing peripheral arterial and venous diseases. The company has developed a minimally invasive mechanical aspiration thrombectomy system that effectively removes peripheral blood clots. This innovative technology not only facilitates the removal of fluid but also aids in breaking up soft emboli and thrombus from the peripheral vasculature. Additionally, the system is capable of infusing and delivering diagnostics or therapeutics, with or without vessel occlusion, thereby transforming the treatment landscape for patients suffering from these conditions.

Bigfoot Biomedical, Inc. is a medical device company focused on transforming diabetes care for individuals with Type 1 Diabetes. Established in 2014 and based in Milpitas, California, the company specializes in developing an integrated diabetes management system that features cloud connectivity and human-centered automation. This system optimizes insulin dosing and delivery through a combination of automated infusion pumps and connected insulin pen options. Bigfoot Biomedical's innovative approach employs machine learning and user-friendly technologies to alleviate the cognitive, emotional, and financial burdens associated with insulin-requiring diabetes. By offering a comprehensive digital drug delivery platform through a unique monthly subscription service model, the company aims to enhance the quality of life for patients managing their diabetes.

Cephea Valve Technologies, Inc. is a medical device company based in San Jose, California, specializing in catheter-delivered solutions for mitral valve regurgitation and coronary artery disease. Founded in 2011, the company develops innovative technologies that facilitate the replacement of mitral valves through minimally invasive procedures. This approach involves delivering an artificial valve via a vein in the leg, eliminating the need for traditional open-heart surgery. By focusing on catheter-based therapies, including balloons and stents for aortic valve replacements, Cephea aims to enhance treatment options for patients suffering from mitral valve disease.

Alere Inc., formerly known as Inverness Medical Innovations, is a company that specializes in diagnostics and health management solutions. It focuses on infectious disease, cardiology, oncology, drugs of abuse, and women's health, offering a wide array of products and services. Alere's portfolio includes over-the-counter tests, lab-based diagnostics, and integrated home monitoring solutions, with notable brands such as Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, and BinaxNOW. The company operates across multiple regions, including North America, Europe, the Middle East, Asia Pacific, and Latin America and Africa. Its medical diagnostic products aim to facilitate the detection of diseases and conditions, empowering patients and healthcare providers to collaboratively manage health outcomes throughout the continuum of care from hospitals to home settings.

St. Jude Medical is a global company based in St. Paul, Minn., that specializes in developing medical technology and services for cardiac, neurological, and chronic pain patients. With a workforce of over 14,000 employees worldwide, the company focuses on providing innovative solutions in cardiac rhythm management, atrial fibrillation, cardiovascular, and neuromodulation. Their product portfolio includes a range of devices such as implantable cardioverter defibrillators, pacemakers, heart valve replacement products, and neurostimulation devices. St. Jude Medical aims to empower healthcare professionals with tools that enhance patient care, reduce risks, and improve treatment outcomes across the globe.

Kalila Medical focuses on developing advanced catheter technologies for vascular and intracardiac access. The company specializes in a platform of steerable sheaths designed to enhance precision during catheter-based procedures, particularly for atrial fibrillation ablation. Its initial product line includes sheaths compatible with both 8Fr and 12Fr ablation catheters, offering improved torque and tip control essential for effective catheter delivery and lesion formation. Beyond atrial fibrillation, Kalila's technology has applications in various endovascular procedures, including mitral valve repair, closure of atrial septal defects and patent foramen ovale, left atrial appendage closure, transseptal puncture, and left ventricular lead placement. Founded in 2010, Kalila Medical emerged from Shifamed LLC, a medical device incubator based in Silicon Valley.

Alere Inc., formerly known as Inverness Medical Innovations, is a company that specializes in diagnostics and health management solutions. It focuses on infectious disease, cardiology, oncology, drugs of abuse, and women's health, offering a wide array of products and services. Alere's portfolio includes over-the-counter tests, lab-based diagnostics, and integrated home monitoring solutions, with notable brands such as Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, and BinaxNOW. The company operates across multiple regions, including North America, Europe, the Middle East, Asia Pacific, and Latin America and Africa. Its medical diagnostic products aim to facilitate the detection of diseases and conditions, empowering patients and healthcare providers to collaboratively manage health outcomes throughout the continuum of care from hospitals to home settings.

SetPoint Medical is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices aimed at treating chronic autoimmune diseases. The company is creating a platform that stimulates the vagus nerve to activate the body's natural inflammatory reflex, leading to a systemic immune-restorative effect. This innovative approach offers an alternative treatment option for conditions such as rheumatoid arthritis and inflammatory bowel disease, with the potential for reduced risks and costs compared to traditional drug therapies. SetPoint Medical, originally known as Innovative Metabolics Inc. until its name change in 2008, aims to provide patients and healthcare providers with effective solutions for managing debilitating inflammatory diseases.

Tendyne Holdings Inc. is a clinical-stage medical device company based in Roseville, Minnesota, focused on developing innovative, minimally invasive therapies for mitral regurgitation, a condition affecting numerous individuals globally each year. Founded in 2010, the company specializes in transcatheter mitral valve replacement and repair technologies. Its primary product is a transcatheter mitral valve prosthesis designed to be deployed without disrupting the native mitral annulus, while preserving the sub-valvular apparatus. The valve can be placed using a transapical approach, allowing physicians to reposition, remove, or redeploy the valve during the procedure. As of August 2015, Tendyne operates as a subsidiary of Abbott Laboratories.

Veropharm is a prominent Russian pharmaceutical manufacturer founded in 1997, known for producing generic drugs, oncological medications, and medical adhesive bandages. The company operates three production facilities located in Voronezh, Belgorod, and Pokrov, with a combined annual production capacity of 591 million tablets and capsules, 7 million ampoules, 468 million adhesive bandages, and 43 million vials. Veropharm offers approximately 240 different medical products across 12 anatomical and therapeutic groups, specializing in areas such as oncology, women's health, gastroenterology, infectious diseases, dermatology, and neurology. The company is recognized both in Russia and internationally, contributing significantly to the pharmaceutical market. As of September 2013, Veropharm operates as a subsidiary of GardenHills OOO.

Topera Medical is a venture-backed medical device company focused on improving the diagnosis and treatment of complex cardiac arrhythmias. The company has developed an innovative 3D analysis and mapping system that assists electrophysiologists in identifying the electrical sources responsible for various arrhythmias, including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia. The Topera System comprises the RhythmView Workstation and the FIRMap diagnostic catheter, which together enable clinicians to visualize the heart's electrical activity in real-time. This dynamic representation aids in more accurate diagnosis and effective treatment planning, ultimately aiming to enhance patient outcomes in cardiac care.

CFR Pharmaceuticals is a prominent multinational pharmaceutical company operating in 15 Latin American countries, including Chile, Peru, Argentina, and Colombia, as well as other emerging markets. The company specializes in the development, manufacture, and commercialization of branded generics and complex injectables. Its diverse portfolio includes therapeutic products in various fields such as neurology, psychiatry, cardiology, women’s health, and respiratory diseases. Key business segments include Drugtech, which focuses on neurology and cardiology; Gynopharm, dedicated to women's health; Recalcine, targeting acute therapeutic areas; and Biomedical Sciences, which involves monoclonal antibodies and treatments for oncology and rheumatology. Additionally, CFR Pharmaceuticals offers complex injectables for critical care and various sterile applications, underscoring its commitment to addressing a wide range of healthcare needs.

UNeLAB develops technology for the automation of laboratory processes and services.

IDEV Technologies is a medical device company dedicated to developing innovative products for endovascular and interventional applications, particularly in the fields of interventional radiology, gastroenterology, vascular surgery, and cardiology. The company markets SUPERA, a unique self-expanding nitinol stent designed with a patented interwoven structure that enhances flexibility, radial strength, and resistance to kinking and crushing. SUPERA has received approval for treating biliary strictures in the United States. Additionally, IDEV is actively enrolling patients in the SUPERB IDE trial to evaluate the stent's safety and efficacy for use in the superficial femoral artery.

OptiMedica Corporation, established in 2004 and based in Silicon Valley, is a global ophthalmic device company focused on enhancing patient outcomes through innovative technologies. The company is dedicated to transforming cataract surgery by developing a reproducible, noninvasive technique that utilizes femtosecond laser technology to replace traditional manual steps, which can be inconsistent. This approach aims to provide cataract surgeons with improved precision, control, performance, and efficacy. OptiMedica has conducted clinical trials for its Catalys Precision Laser System, yielding promising results. Although the system is not available for sale in the United States at this time, OptiMedica anticipates launching it in both U.S. and international markets.

Respicardia, Inc. is focused on enhancing the health of heart failure patients through the development and manufacturing of implantable stimulation therapy solutions. The company's primary product, the remedē System, is an implantable device designed to restore natural breathing patterns during sleep in patients with central sleep apnea. This device utilizes transvenous neurostimulation technology to stimulate the phrenic nerve, thereby improving respiratory rhythm management and overall cardiovascular health. Founded in 2006 and based in Minnetonka, Minnesota, Respicardia aims to improve patient outcomes through innovative therapies that address the critical needs of those suffering from respiratory and cardiovascular diseases. The company has also established a strategic partnership with Sorin Group to further its mission.

Piramal Healthcare Solutions provides pharma and health care services.

Facet Biotech Corporation is a biotechnology company focused on the identification and development of oncology drugs. Established as a spin-off from PDL BioPharma in 2008 and later acquired by Abbott Labs, Facet is headquartered in Redwood City, California. The company's pipeline includes several monoclonal antibodies in various stages of clinical development, such as Daclizumab, currently in Phase IIb studies, and Volociximab, which is in Phase I studies. Other notable candidates include Elotuzumab, PDL192, and TRU-016, targeting a range of conditions including multiple myeloma and B-cell malignancies. Additionally, Facet Biotech has established collaboration and license agreements with several pharmaceutical companies, enhancing its research and development capabilities in oncology and other therapeutic areas.

STARLIMS provides Laboratory Information Management Software (LIMS) to help laboratories optimize data management, accessibility, integrity and long-term value.

PanGenetics B.V., based in Utrecht, Netherlands, specializes in the development of monoclonal antibodies aimed at treating immune-mediated diseases. The company focuses on advancing antibodies from late-stage research to clinical proof of concept, utilizing a lean business model that outsources manufacturing and clinical development to specialized providers. Among its clinical programs is PG110, along with PG102, a CD40 antagonist currently undergoing evaluation in a clinical study for patients with psoriatic arthritis. Additionally, PanGenetics employs an in-licensing model to expand its portfolio of antibody-based therapeutic products. The company's strategic approach allows it to concentrate on its core competencies while leveraging external expertise for other critical functions.

Solvay Pharmaceuticals B.V. operates as a pharmaceutical and drugs company. The company is based in Weesp, the Netherlands. Solvay Pharmaceuticals operated as a subsidiary of [Solvay SA](/organization/solvay) until it was acquired by [Abbott Labs](/organization/abbott) in 2009.

Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Visiogen, Inc. is an ophthalmic medical device company focused on developing innovative vision solutions for patients with cataracts, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless range of near, intermediate, and distance vision without the need for glasses or contact lenses. This advanced device is supplied in a pre-loaded injector to minimize lens handling during surgical procedures. Visiogen's technology has received CE Mark approval in Europe and is currently in clinical trials in the United States, aiming to enhance the quality of life for cataract patients through improved vision correction options.

Abbott is a global healthcare company focused on advancing health and well-being through a diverse array of products. The company manufactures and markets cardiovascular devices, diabetes management solutions, nutritional products for both adults and children, and diagnostic tools. Notable offerings include pacemakers, implantable cardioverter defibrillators, continuous glucose monitors, and a wide range of branded generic pharmaceuticals. Abbott is also a leader in molecular diagnostics, providing innovative technologies for disease diagnosis, therapy selection, and disease monitoring, with a strong portfolio of over 350 products. Headquartered in Mumbai, Abbott India Limited, a subsidiary of Abbott Laboratories, plays a significant role in providing high-quality medicines across various therapeutic areas such as women's health, cardiology, and gastroenterology. Approximately 60% of Abbott's sales come from international markets, reflecting its extensive global reach and commitment to enhancing health outcomes worldwide.

Ibis Biosciences, Inc. is involved in the development, manufacturing, and marketing of products designed for the identification and characterization of infectious agents, including bacteria, viruses, fungi, and protozoa. The company offers the Ibis T5000 Biosensor System, a hardware platform that provides insights into drug resistance, virulence, and strain types. Additionally, Ibis Biosciences produces assay kits and panels for strain genotyping, along with essential consumables such as plates, buffers, and reagents for PCR. The company also provides various assay services, including human forensics, bacterial and viral detection, and surveillance services. Its products serve multiple applications in clinical research, healthcare-associated infection control, forensic analysis, and epidemiological surveillance. Founded in 2006 and headquartered in Carlsbad, California, Ibis Biosciences operates as a subsidiary of Abbott Molecular Inc.

Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Nova Science was established in 1999 by Jim Coleman, the previous founder of Chiroxia. Mr. Coleman, a vascular surgeon, has been a senior medical director of various multinational firms including Tyco.

IntraLase Corporation is a leader in the first step of LASIK surgery, the most common means of surgical vision correction. They design, develop and market a laser, related software and disposable devices used to create a cut of tissue across the cornea of a patient’s eye, or a corneal flap, which is the first step in LASIK surgery. Their advanced laser technology improves the safety, precision and visual acuity of LASIK surgery by providing a computer-controlled laser solution as an alternative to the traditional method of creating the corneal flap using a hand-held mechanical, metal-bladed device called a microkeratome. They believe their product offering will become the new standard of care for corneal flap creation. As of April 2, 2007, IntraLase Corp. was acquired by Advanced Medical Optics Inc.

Ovalis is a biotechnology company that develops catheter-based medical devices for the repair of cardiovascular defects.The company is based in Mountain View, California.

KOS Pharmaceuticals manufactures prescription products for the treatment of chronic cardiovascular diseases. Their products are used treatment of primary hypercholesterolemia and mixed dyslipidemia, mixed lipid disorders, and non dihydropyridine calcium channel blocker, enabling doctors to treat hypertension and chronic stable angina.

Ovalis is a biotechnology company that develops catheter-based medical devices for the repair of cardiovascular defects.The company is based in Mountain View, California.

Spine Next is a France-based biotechnology company that specializes in the manufacture and marketing of orthopedic spinal implant devices intended for spinal fusion surgeries. Founded in 1999, the company has developed innovative products such as the Wallis system, a stabilization device designed to treat degenerative disc disease without the need for vertebral fusion. Spine Next was acquired by Abbott on October 25, 2004, enhancing its capabilities and market presence in the orthopedic medical device sector.

Experimental and Applied Sciences is a manufacturer and provider of nutritional supplements, focusing on products that promote health and fitness. The company offers a diverse range of over 70 active nutrition items, including ready-to-drink shakes, powders, energy and low-carbohydrate bars, high-protein snacks, thermogenic beverages, and sports nutrition products. These products are marketed directly to consumers as well as through mass merchandisers and specialty retailers, aiming to cater to individuals seeking to enhance their nutritional intake and overall well-being.

TheraSense develop and sell easy to use glucose self-monitoring systems for peoplewith diabetes that dramatically reduce the pain of testing. Using ourproprietary technologies, we have developed products that are less painful touse than current products on the market. FreeStyle, our first product, canaccurately measure glucose levels in a blood sample that is a fraction of thesample size required by other systems. This small sample requirement enablesusers to obtain the sample from their forearms, and thereby dramaticallyreduces the pain and inconvenience associated with a larger blood sample takenfrom their fingertips.

i-STAT Corporation develops, manufactures and markets diagnostic products for blood analysis that provide health care professionals critical diagnostics information accurately and immediately at the point of patient care.

Hydra Biosciences is a biopharmaceutical company located in Cambridge, Massachusetts, focused on developing innovative drugs for pain, inflammation, cardiovascular diseases, and other conditions. The company utilizes its expertise in novel ion channels, specifically targeting Transient Receptor Potential (TRP) ion channels, to create selective and safer therapeutic options. Hydra employs proprietary high-throughput screening platforms that facilitate the identification and development of drug candidates aimed at addressing significant unmet medical needs. With a strong intellectual property portfolio and a flexible approach to drug discovery, Hydra differentiates itself from traditional biopharmaceutical firms. The company has attracted substantial financing from notable investors, enabling it to advance its drug development programs effectively.

Integrated Vascular Systems, Inc. designs, manufactures, and develops blood vessel closure devices for the healthcare industry. The company's products allow closure of femoral artery incisions during surgical procedures.

ZonePerfect Nutrition is a provider of nutrition bars and various products aimed at enhancing immunity and promoting healthy living. The company offers a range of flavors, including classic, dark chocolate, cookie dough, and sweet and salty options. Its product formulations adhere to a balanced 40/30/30 ratio of carbohydrates, protein, and dietary fat, positioning the brand within the growing healthy living and weight control markets. ZonePerfect Nutrition distributes its products through major food, drug, and mass merchandisers across the United States, as well as through a direct-to-consumer program.

Manufactures and distributes medical device which is used to provide relief for nausea and vomitting from various causes.

Spinal Concepts is a biotechnology company focused on spinal fixation products used in the treatment of spinal disorders, diseases, and injuries. The company was founded by Erin McGurk in 1996.

Vysis is a genomic disease management company that focuses on developing, commercializing, and marketing clinical products essential for the evaluation and management of cancer, prenatal disorders, and other genetic diseases. The company specializes in detecting genetic abnormalities across the 46 human chromosomes, which are critical in understanding human diseases. Vysis holds a significant position in the market as the first company to receive FDA clearance for a genomic product utilizing fluorescence in situ hybridization (FISH). It currently offers four FDA-cleared clinical products and has a portfolio of over 240 research products available in the United States and Europe, supported by a global distribution network across 28 countries. The company operates more than 320 proprietary genetic workstations installed at 224 laboratories in 18 countries. Additionally, Vysis has a robust pipeline of nine clinical products under development, bolstered by collaborations with renowned medical research institutions such as the University of California, San Francisco, and the Mayo Clinic.

Abbott is a global healthcare company focused on advancing health and well-being through a diverse array of products. The company manufactures and markets cardiovascular devices, diabetes management solutions, nutritional products for both adults and children, and diagnostic tools. Notable offerings include pacemakers, implantable cardioverter defibrillators, continuous glucose monitors, and a wide range of branded generic pharmaceuticals. Abbott is also a leader in molecular diagnostics, providing innovative technologies for disease diagnosis, therapy selection, and disease monitoring, with a strong portfolio of over 350 products. Headquartered in Mumbai, Abbott India Limited, a subsidiary of Abbott Laboratories, plays a significant role in providing high-quality medicines across various therapeutic areas such as women's health, cardiology, and gastroenterology. Approximately 60% of Abbott's sales come from international markets, reflecting its extensive global reach and commitment to enhancing health outcomes worldwide.

Glaxo Wellcome - Anesthesia Business Included in the acquisition are four neuromuscular blockers (muscle relaxants) and Ultiva &reg ; (remifentanil ), an ultra-short acting analgesic.

Perclose, Inc. designs, develops, manufactures, and markets a family of medical devices that automate the surgical closure or connection of blood vessels. It offers Perclose percutaneous vascular surgery devices, which surgically close the arterial access site in the femoral artery after catheterization procedures, such as angioplasty, stenting, atherectomy, and diagnostic angiography; and Heartflo Anastomosis System, which allows cardiac surgeons to automate the rapid placement of sutures in blood vessels during coronary artery bypass graft surgery.

ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

Murex develops, manufactures and markets a wide range of products for the detection, screening and monitoring of infectious diseases and other medical conditions.

Sanofi - Parenteral Products Businesses makes pre-filled, single-dose syringe technology.

MediSense, Inc. was engaged in the development, manufacture, and marketing of self-testing blood glucose monitoring systems that enabled people with diabetes to manage their disease effectively.

Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.